Millions are losing weight on Ozempic and Wegovy - here's what an orthopedic surgeon wants every patient to know

Key Points:

• GLP-1 medications like Ozempic, Wegovy, and Mounjaro are effective for significant weight loss, offering benefits such as reduced joint pain and improved cardiovascular health, especially by decreasing the load on weight-bearing joints.
• However, these drugs can also cause muscle loss, which may negatively impact bone density and joint health, increasing risks of injuries and fractures, particularly in postmenopausal women and older adults.
• Dr. Brian Nwannunu recommends that patients on GLP-1 drugs monitor their weekly weight loss, maintain adequate protein intake, and engage in resistance training to preserve muscle mass and support bone strength.
• While routine bone density scans and supplements are not necessary for all patients, regular lab work to check for vitamin deficiencies and tailored medical advice are important to prevent adverse effects.
• Emerging research suggests GLP-1 users may have lower infection rates after joint replacement surgery, but ongoing monitoring and personalized medical guidance remain crucial to safely manage long-term risks associated with these medications.